Olaparib for DNA repair-deficient prostate cancer - one for all, or all for one?

Nat Rev Clin Oncol. 2020 Aug;17(8):455-456. doi: 10.1038/s41571-020-0395-x.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • DNA Repair / genetics
  • Humans
  • Male
  • Phthalazines / therapeutic use
  • Piperazines / therapeutic use
  • Prostatic Neoplasms, Castration-Resistant*

Substances

  • Phthalazines
  • Piperazines
  • olaparib